Centrica

WORST BEHIND FOR CENTRICA? (BUY, 40% UPSIDE)

17/06/20 -"Over the last five years Centrica's (Buy, UK) share has been plummeting, and the turbulence at the beginning of this year will lead to a delay in the announced restructuring plan. However, we also ..."

PDF page sample
Pages
54
Language
English
Published on
17/06/20
Download
You may also be interested by these reports :
09/11/26
We have raised our 2026 estimates to reflect a stronger-than-expected 9M26 and the upgraded guidance, now c.€5.4bn of recurring EBITDA and ...
06/11/26
EDP delivered a strong quarter and its third guidance upgrade of the year. 3Q26 recurring EBITDA jumped 26%, taking 9M26 recurring net profit up 22% ...
06/11/26
ANEEL votes on 17 November on recommending the early termination of Enel’s São Paulo distribution concession. With two directors already in favour, a ...
05/11/26
We reiterate our Buy rating. Potential EPS upside leaves the dividend well covered, and at €1.42 per share it offers a 6% yield, which we find highly ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO